Atefeh Abedini

1.4k total citations
90 papers, 799 citations indexed

About

Atefeh Abedini is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Atefeh Abedini has authored 90 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 23 papers in Physiology and 17 papers in Infectious Diseases. Recurrent topics in Atefeh Abedini's work include Sarcoidosis and Beryllium Toxicity Research (16 papers), COVID-19 Clinical Research Studies (11 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Atefeh Abedini is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (16 papers), COVID-19 Clinical Research Studies (11 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Atefeh Abedini collaborates with scholars based in Iran, United Kingdom and Canada. Atefeh Abedini's co-authors include Arda Kiani, Hamidreza Jamaati, Ian M. Adcock, Esmaeil Mortaz, Farzaneh Dastan, Ali Saffaei, Seyed Alireza Nadji, Reza Lashgari, Payam Tabarsi and Maryam Alsadat Hashemipour and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Development.

In The Last Decade

Atefeh Abedini

81 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atefeh Abedini Iran 15 226 171 137 131 114 90 799
Arda Kiani Iran 15 282 1.2× 155 0.9× 166 1.2× 126 1.0× 97 0.9× 96 754
Vincenzo Venerito Italy 20 233 1.0× 95 0.6× 147 1.1× 132 1.0× 52 0.5× 91 1.1k
Chunguo Jiang China 11 194 0.9× 136 0.8× 86 0.6× 72 0.5× 33 0.3× 32 520
Melanie C. Bois United States 17 287 1.3× 356 2.1× 62 0.5× 162 1.2× 292 2.6× 99 1.3k
Anil Pathare Oman 20 98 0.4× 128 0.7× 177 1.3× 161 1.2× 145 1.3× 155 1.7k
Éva Ajzner Hungary 17 153 0.7× 125 0.7× 117 0.9× 114 0.9× 97 0.9× 43 824
Federica Bellerba Italy 16 153 0.7× 128 0.7× 71 0.5× 150 1.1× 53 0.5× 44 832
Luca Carmisciano Italy 14 122 0.5× 71 0.4× 48 0.4× 46 0.4× 100 0.9× 51 609
Magnus Sköld Sweden 18 498 2.2× 62 0.4× 203 1.5× 171 1.3× 63 0.6× 77 1.0k
Le Kang United States 18 233 1.0× 55 0.3× 67 0.5× 129 1.0× 163 1.4× 88 1.0k

Countries citing papers authored by Atefeh Abedini

Since Specialization
Citations

This map shows the geographic impact of Atefeh Abedini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atefeh Abedini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atefeh Abedini more than expected).

Fields of papers citing papers by Atefeh Abedini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atefeh Abedini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atefeh Abedini. The network helps show where Atefeh Abedini may publish in the future.

Co-authorship network of co-authors of Atefeh Abedini

This figure shows the co-authorship network connecting the top 25 collaborators of Atefeh Abedini. A scholar is included among the top collaborators of Atefeh Abedini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atefeh Abedini. Atefeh Abedini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Yalun, Atefeh Abedini, Galaxia M. Rodriguez, et al.. (2025). Loss of LATS1 and LATS2 promotes ovarian tumor formation by enhancing AKT activity and PD-L1 expression. Oncogene. 44(27). 2240–2252. 1 indexed citations
2.
Barough, Mahdieh Shokrollahi, Zahra Sadat Hashemi, Hassan Sanati, et al.. (2023). Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19. Pilot and Feasibility Studies. 9(1). 137–137. 6 indexed citations
4.
Dizaji, Mehdi Kazempour, Mohammad Varahram, Payam Tabarsi, et al.. (2023). Prediction of multidrug-resistant tuberculosis in tuberculosis patients using perceptron artificial neural networks model. 2(2). 90–98. 1 indexed citations
5.
Abedini, Atefeh, et al.. (2023). Missed bronchial web in a 4‐year‐old boy with foreign body aspiration: A case report. SHILAP Revista de lepidopterología. 11(2). e6765–e6765. 1 indexed citations
6.
Dizaji, Mehdi Kazempour, et al.. (2022). Simulation of COVID-19 disease epidemic in Iran based on SIR model. 1(1). 1–9.
7.
Zabeh, Erfan, Michael Rieder, Safieddin Safavi‐Naeini, et al.. (2021). A machine learning based exploration of COVID-19 mortality risk. PLoS ONE. 16(7). e0252384–e0252384. 55 indexed citations
8.
Rezaei, Abbas, Atefeh Fakharian, Fariba Ghorbani, et al.. (2020). Comparison of high‐flow oxygenation with noninvasive ventilation in COPD exacerbation: A crossover clinical trial. The Clinical Respiratory Journal. 15(4). 420–429. 15 indexed citations
9.
Ahmadi, Zargham Hossein, Behrooz Farzanegan, Payam Tabarsi, et al.. (2020). Extracorporeal membrane oxygenation and COVID‐19: The causes of failure. Journal of Cardiac Surgery. 35(10). 2838–2843. 6 indexed citations
10.
Dastan, Farzaneh, Ali Saffaei, Hamidreza Jamaati, et al.. (2020). Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19. Journal of Global Antimicrobial Resistance. 21. 340–341. 33 indexed citations
11.
Sadr, Makan, et al.. (2020). Angioembolization in massive hemoptysis for a patient with acute coronary syndrome and history of hydatid cyst. Journal of Cardiology Cases. 23(5). 231–233. 1 indexed citations
12.
Baghaei, Parvaneh, Farzaneh Dastan, Majid Marjani, et al.. (2020). Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients. International Immunopharmacology. 92. 107329–107329. 12 indexed citations
13.
Farrokhpour, Mohsen, Arda Kiani, Esmaeil Mortaz, et al.. (2019). Procalcitonin and Proinflammatory Cytokines in Early Diagnosis of Bacterial Infections after Bronchoscopy. Open Access Macedonian Journal of Medical Sciences. 7(6). 913–919. 6 indexed citations
14.
Sharif-Kashani, Babak, et al.. (2019). The Relationship between Electrocardiographic Changes and Prognostic Factors in Severely Symptomatic Pulmonary Hypertension.. PubMed Central. 18(1). 34–40. 6 indexed citations
15.
Kiani, Arda, et al.. (2018). Outpatient pleuroscopy: Report of an experience in a referral hospital.. PubMed. 65(3). 142–5.
16.
Mostafaei, Shayan, et al.. (2017). Human endogenous retrovirus env genes: Potential blood biomarkers in lung cancer. Microbial Pathogenesis. 115. 189–193. 38 indexed citations
18.
Mortaz, Esmaeil, Hamidreza Jamaati, Mostafa Alavi-Moghaddam, et al.. (2016). Role of Innate Lymphoid Cells in Lung Disease. SHILAP Revista de lepidopterología. 14 indexed citations
19.
Samieirad, Sahand, et al.. (2015). Retrospective study maxillofacial fractures epidemiology and treatment plans in Southeast of Iran. Medicina oral, patología oral y cirugía bucal. 20(6). e729–e736. 41 indexed citations
20.
Abedini, Atefeh, et al.. (2012). Comparison of Different Methods of Education on Reducing the Anxiety of Patients with Myocardial Infarction. SHILAP Revista de lepidopterología. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026